Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Garvey et al
Figure 1, Tables 1-4
Files in this Data Supplement:
Supplemental data
- Figure 1
Supplemental data
- Tables 1-4, Figure 1 legend